The Newsroom

Investigations  /  02.23.2021

Investigation of Immunovant, Inc.

Immunovant, Inc. (IMVT) Misled Shareholders About the Viability of its Drug Candidate IMVT-1401 On September ...

READ MORE
Investigations  /  02.23.2021

Investigation of EHang Holdings Limited

EHang Holdings Limited (EH) Mischaracterized its Lead Product and Misled Shareholders Regarding its Financial Success ...

READ MORE
Investigations  /  02.23.2021

Investigation of QuantumScape Corporation

QuantumScape Corporation (QS) Misled Shareholders by Overstating the Viability, Power and Life of its Solid-State ...

READ MORE
Investigations  /  02.22.2021

Investigation of fuboTV, Inc.

FuboTV, Inc. (FUBO) Misled Shareholders About Multiple Facets of Its Business Operations and Performance Metrics ...

READ MORE
Investigations  /  02.22.2021

Investigation of SolarWinds Corporation

SolarWinds Corporation (SWI) Misled Shareholders About Its Security Safeguards       SolarWinds regularly touted its robust ...

READ MORE
Investigations  /  02.22.2021

Investigation of Jianpu Technology, Inc.

Jianpu Technology Inc. (JT) Misled Shareholders About Its Business, Operations, and Prospects       Throughout the ...

READ MORE
Investigations  /  02.17.2021

Investigation of Bluebird Bio, Inc.

Bluebird Bio, Inc. (BLUE) Misled Shareholders About the Viability of LentiGlobin      According to the ...

READ MORE
Investigations  /  02.17.2021

Investigation of Splunk Inc.

Splunk, Inc. (SPLK) Misled Shareholders About its Third Quarter 2021 Financial Results     On October ...

READ MORE
Investigations  /  02.15.2021

Investigation of QuantumScape Corporation

QuantumScape Corporation (QS) Misled Shareholders by Overstating the Viability, Power, and Life of its Solid-State ...

READ MORE
Investigations  /  02.15.2021

Investigation of Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc. (VYGR) Misled Shareholders Regarding the Viability of its Lead Clinical Candidate for ...

READ MORE


How can we help you?

CONTACT US TODAY | 1 800 350 6003 or [email protected]

Tell us your concerns